(Q44453818)

English

Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children.

scientific article published on 21 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Stefania Bernardi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Guido Castelli-Gattinara

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Gatti G

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Cruciani M

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

De Pascalis CR

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Pontali E

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Papa L

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Miletich F

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bassetti D

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

21 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1476-1482

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766843%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Nelfinavir: an update on its use in HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland.

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability.

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Therapeutic drug monitoring as a tool in treating HIV infection.

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Drug interactions of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

1 reference

https://api.crossref.org/works/10.1086%2F375062

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44453818&oldid=2144133934"